324 related articles for article (PubMed ID: 19007431)
1. Targeting the UPS as therapy in multiple myeloma.
Chauhan D; Bianchi G; Anderson KC
BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S1. PubMed ID: 19007431
[TBL] [Abstract][Full Text] [Related]
2. Patented small molecule inhibitors in the ubiquitin proteasome system.
Guédat P; Colland F
BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S14. PubMed ID: 18047738
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition in multiple myeloma: therapeutic implication.
Chauhan D; Hideshima T; Anderson KC
Annu Rev Pharmacol Toxicol; 2005; 45():465-76. PubMed ID: 15822185
[TBL] [Abstract][Full Text] [Related]
4. The UPS: a promising target for breast cancer treatment.
Sato K; Rajendra E; Ohta T
BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S2. PubMed ID: 19007432
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin system, disease, and drug discovery.
Petroski MD
BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S7. PubMed ID: 19007437
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib as an antitumor agent.
Roccaro AM; Hideshima T; Richardson PG; Russo D; Ribatti D; Vacca A; Dammacco F; Anderson KC
Curr Pharm Biotechnol; 2006 Dec; 7(6):441-8. PubMed ID: 17168660
[TBL] [Abstract][Full Text] [Related]
7. Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy.
Driscoll JJ; Dechowdhury R
Target Oncol; 2010 Dec; 5(4):281-9. PubMed ID: 21125340
[TBL] [Abstract][Full Text] [Related]
8. Biologic impact of proteasome inhibition in multiple myeloma cells--from the aspects of preclinical studies.
Hideshima T; Anderson KC
Semin Hematol; 2012 Jul; 49(3):223-7. PubMed ID: 22726545
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of action and determinants of sensitivity to the proteasome inhibitor bortezomib in multiple myeloma therapy].
Ri M
Rinsho Ketsueki; 2016 May; 57(5):537-45. PubMed ID: 27263777
[TBL] [Abstract][Full Text] [Related]
10. Targeting the ubiquitin proteasome system in haematological malignancies.
Crawford LJ; Irvine AE
Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitor therapy in multiple myeloma.
Chauhan D; Hideshima T; Mitsiades C; Richardson P; Anderson KC
Mol Cancer Ther; 2005 Apr; 4(4):686-92. PubMed ID: 15827343
[TBL] [Abstract][Full Text] [Related]
12. Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.
Nury D; Doucet C; Coux O
BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S7. PubMed ID: 18047744
[TBL] [Abstract][Full Text] [Related]
13. Targeting proteasomes as therapy in multiple myeloma.
Chauhan D; Hideshima T; Anderson KC
Adv Exp Med Biol; 2008; 615():251-60. PubMed ID: 18437898
[TBL] [Abstract][Full Text] [Related]
14. Role of the ubiquitin proteasome system in Alzheimer's disease.
Upadhya SC; Hegde AN
BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S12. PubMed ID: 18047736
[TBL] [Abstract][Full Text] [Related]
15. [Classification and synthesis of ubiquitin-proteasome inhibitor].
Li J; Zhang DY; Wu XM
Yao Xue Xue Bao; 2009 Dec; 44(12):1313-9. PubMed ID: 21351462
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-proteasome system as a target for anticancer treatment-an update.
Kim YJ; Lee Y; Shin H; Hwang S; Park J; Song EJ
Arch Pharm Res; 2023 Jul; 46(7):573-597. PubMed ID: 37541992
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitors in the clinical setting: benefits and strategies to overcome multiple myeloma resistance to proteasome inhibitors.
Cheriyath V; Jacobs BS; Hussein MA
Drugs R D; 2007; 8(1):1-12. PubMed ID: 17249845
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.
Mittenberg AG; Kuzyk VO; Shabelnikov SV; Gorbach DP; Shatrova AN; Fedorova OA; Barlev NA
Cell Cycle; 2018; 17(14):1745-1756. PubMed ID: 30009671
[TBL] [Abstract][Full Text] [Related]
19. Resistance to proteasome inhibitors and other targeted therapies in myeloma.
Wallington-Beddoe CT; Sobieraj-Teague M; Kuss BJ; Pitson SM
Br J Haematol; 2018 Jul; 182(1):11-28. PubMed ID: 29676460
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors.
Johnson DE
Endocr Relat Cancer; 2015 Feb; 22(1):T1-17. PubMed ID: 24659480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
